Duraj F et al. |
[Intestinal transplantation. The first Swedish transplantation of the small intestine in an adult patient with pseudoobstruction]. |
1998 |
Lakartidningen |
pmid:9700261
|
Matsumoto T et al. |
Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits. |
1998 |
Atherosclerosis |
pmid:9699896
|
|
[Tacrolimus in kidney transplantation. Bürgenstock, Switzerland, 20 March 1998]. |
1998 |
Dtsch. Med. Wochenschr. |
pmid:9697633
|
Rejto PA and Verkhivker GM |
Molecular anchors with large stability gaps ensure linear binding free energy relationships for hydrophobic substituents. |
1998 |
Pac Symp Biocomput |
pmid:9697196
|
Mihatsch MJ et al. |
The side-effects of ciclosporine-A and tacrolimus. |
1998 |
Clin. Nephrol. |
pmid:9696431
|
Moriwaki A et al. |
An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. |
1998 |
Neuroscience |
pmid:9692722
|
Ding JM et al. |
A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. |
1998 |
Nature |
pmid:9690474
|
Kilmartin DJ et al. |
Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. |
1998 |
Ocul. Immunol. Inflamm. |
pmid:9689640
|
Tsuzuki S et al. |
FK506 (tacrolimus) inhibits extravasation of lymphoid cells by abrogating VLA-4/VCAM-1 mediated transendothelial migration. |
1998 |
FEBS Lett. |
pmid:9688583
|
Medh RD et al. |
Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants. |
1998 |
Mol. Cell. Endocrinol. |
pmid:9685211
|
Peces R et al. |
Alloimmune haemolytic anaemia resulting from anti-A and anti-B antibody induced by group O graft in renal transplant recipients. |
1998 |
Nephrol. Dial. Transplant. |
pmid:9681751
|
Grupp C et al. |
Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer? |
1998 |
Nephrol. Dial. Transplant. |
pmid:9681701
|
Hultsch T et al. |
Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. |
1998 |
Arch. Dermatol. Res. |
pmid:9681677
|
Van Leent EJ et al. |
Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. |
1998 |
Arch Dermatol |
pmid:9681343
|
Denesyuk AI et al. |
Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin. |
1998 |
Comput. Chem. |
pmid:9680690
|
Sanchez-Campos S et al. |
Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. |
1998 |
Transplantation |
pmid:9679826
|
Fisher NC et al. |
Chronic renal failure following liver transplantation: a retrospective analysis. |
1998 |
Transplantation |
pmid:9679823
|
Onuma H et al. |
A calcineurin inhibitor, FK506, blocks voltage-gated calcium channel-dependent LTP in the hippocampus. |
1998 |
Neurosci. Res. |
pmid:9678635
|
Salowe SP and Hermes JD |
Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes. |
1998 |
Arch. Biochem. Biophys. |
pmid:9675023
|
Yardin C et al. |
FK506 antagonizes apoptosis and c-jun protein expression in neuronal cultures. |
1998 |
Neuroreport |
pmid:9674596
|